ライフサイエンスコーパス: vaccinate

1 tug of war for iron may provide a new way to vaccinate.

2 ed toxins against which the patient could be vaccinated.

3 e used to adjust for the likelihood of being vaccinated.

4 ls within the labor-sending communities were vaccinated.

5 eptibility was detected among the repeatedly vaccinated.

6 ia is common and almost all children are BCG-vaccinated.

7 zing antibodies than naive subjects who were vaccinated.

8 nt women and infants who are too young to be vaccinated.

9 but fewer than half of these travelers were vaccinated.

10 ding similar levels of efficiency per person vaccinated.

11 21, 2013, and Jan 11, 2016, we enrolled and vaccinated 101 participants with 306 doses of mRNA (80-6

12 were eligible, 2539 consented, and 2041 were vaccinated 21 days after randomisation).

13 cRCTs in which preschool-aged children were vaccinated: 22% (95% CI, 1%-38%; I2 = 0%; N = 1903) agai

14 rved increased A(H3N2) infection among those vaccinated 3 consecutive years.

15 s also significantly reduced among HPV-16/18-vaccinated (4.1%) compared with unvaccinated subjects (1

16 Vaccinating 40% of boys along with 60% of girls yielded

17 communities where school-aged children were vaccinated: 60% (95% confidence interval [CI], 41%-72%;

18 However, ILI incidence was similar between vaccinated (7.6% and 10.8%) and nonvaccinated (4.2% and

19 9.6% (CI, 8.4% to 10.8%) of candidates were vaccinated, 7.5% (CI, 6.4% to 8.6%) had no documented va

20 Vaccinating a buffer of individuals around a case (ring

21 The proportion of Tdap-vaccinated adult CCs was similar between cases and contr

22 sfer of antisera or CD4(+) T cells from PhtD-vaccinated adult mice led to a nonsignificant reduction

23 Depletion of CD4(+) T cells in PhtD-vaccinated adult mice, but not PCV13-vaccinated mice, ca

24 20-vaccinated infants but only in 12% of the vaccinated adults (P = 0.0018).

25 , there have been no recurrences in patients vaccinated after receiving trastuzumab as part of standa

26 Best Practice Advice 1: Clinicians should vaccinate against hepatitis B virus (HBV) in all unvacci

27 As compared to individuals never vaccinated against influenza A(H1N1)pdm09, the highest e

28 e four dengue viruses or West Nile virus, or vaccinated against yellow fever virus.

29 Three vaccinated and 10 unvaccinated laboratory-confirmed case

30 um samples were obtained at 7 months from 42 vaccinated and 24 unvaccinated participants.

31 -olds in 2011-2014 decreased 89% among those vaccinated and 34% among those unvaccinated.

32 Based on live pup births in the vaccinated and control groups (94.1% versus 63.6%), the

33 iduals, who had given informed consent, were vaccinated and followed up for 21 days under good clinic

34 In PLGA-KAg vaccinated and heterologous SwIV H1N1 challenged pigs, c

35 ectiveness depends strongly on the age group vaccinated and local transmission intensity.

36 d declines in rotavirus infection and AGE in vaccinated and unvaccinated age groups within 1 year of

37 illomavirus (HPV) prevalence among HPV-16/18-vaccinated and unvaccinated Finnish male adolescents par

38 No differences were detected between the vaccinated and unvaccinated groups in risk for inpatient

39 ere used to compare disease severity between vaccinated and unvaccinated patients, adjusting for timi

40 cine immediately; vaccination protected both vaccinated and unvaccinated people in those clusters.

41 s (IRRs) of suspected and confirmed cases in vaccinated and unvaccinated populations were estimated w

42 The mean (SD) ages of vaccinated and unvaccinated women were 31.6 (5.2) and 30

43 e, 2151 consented, and 2119 were immediately vaccinated) and 4557 contacts and contacts of contacts i

44 n total, 35,612 (46.5%) individuals were BCG vaccinated, and 5,870 (7.7%) had asthma.

45 pe HPV (HPV-6, -11, -16, and -18) among all, vaccinated, and unvaccinated women at waves 1, 2, and 3,

46 uman donors with natural HCMV infection or a vaccinated animal, we mapped eight sites on the dominant

47 gher in comparison to those in VC2- and mock-vaccinated animals (P < 0.01 or P < 0.001).

48 d markedly lower influenza titers than RD-Ad-vaccinated animals after challenge with influenza A/PR/8

49 After challenging the vaccinated animals at month 8 with H3N2 viruses, the cVL

50 Vaccinated animals demonstrated stronger acute viral pul

51 position of C3d in the corneal epithelium of vaccinated animals following challenge and delayed viral

52 nasopharyngeal virulent bacterial burden of vaccinated animals was substantially reduced (0.002%) co

53 ed plasma cells and plasmablasts compared to vaccinated animals.

54 connected individuals are more likely to get vaccinated, as are people who are exposed to friends who

55 ing of viral nucleic acids from the stool of vaccinated, asymptomatic children and their close contac

56 Girls vaccinated at 12 years of age with 2 (at 0 and 6 months)

57 effectiveness of 89.1% (85.1-92.3) for those vaccinated at age 12-13 years.

58 age 9 years to 6% (range: 6-7%) among women vaccinated at age 45 years.

59 cancer varied from 55% (53-56%) among women vaccinated at age 9 years to 6% (range: 6-7%) among wome

60 Of the MMR-eligible, 3477 (53%) were not vaccinated at the visit; of these, 1689 (48%) were not v

61 When BPZE1-vaccinated baboons were challenged with a high dose of a

62 at the visit; of these, 1689 (48%) were not vaccinated because of traveler refusal, 966 (28%) becaus

63 increasingly evident, especially among girls vaccinated before HPV exposure in countries with high va

64 ns exemplify a complex, coupled system where vaccinating behavior and disease dynamics influence one

65 sults support the hypothesis that population vaccinating behavior near the disease elimination thresh

66 Understanding individuals' voluntary vaccinating behaviors plays essential roles in making va

67 HZV-vaccinated beneficiaries were matched to unvaccinated be

68 Infants vaccinated between 6 and 14 months of age had a lower ri

69 ased to euro70 (95% CrI, euro40-euro100) per vaccinated boy.

70 d was euro240 (95% CrI, euro200-euro280) per vaccinated boy.

71 Vaccinating boys along with girls is only modestly less

72 Vaccinating boys in addition to girls increased the RRpr

73 Vaccinating boys may be an appealing complementary strat

74 We evaluated the efficiency of vaccinating boys relative to increasing vaccine uptake a

75 cremental cost-effectiveness ratio (ICER) of vaccinating boys was euro9134/LY (95% credible interval

76 Because of the high risk of reinfection, vaccinating boys who have not yet been exposed may be cr

77 Mice vaccinated by intradermal injection using the jet inject

78 most likely arose from unvaccinated or under-vaccinated canines, not from a novel CPV strain incapabl

79 d occurred by 10 days postinfection (dpi) in vaccinated cattle and by 21 dpi in nonvaccinated animals

80 As a consequence, vaccinated CD47-deficient mice demonstrated better contr

81 eloping and refining approaches to reach and vaccinate children and other vulnerable populations in c

82 ncidences decreased between 2005 and 2016 in vaccinated children (by 68.5%), and in the whole populat

83 Among fully vaccinated children aged 2-17 years, the effectiveness o

84 lines in overall and vaccine-serotype IPD in vaccinated children and in unvaccinated persons.

85 influenza A or B virus in all participants (vaccinated children and persons who did not receive the

86 eactive T-cell response in 14 trivalent LAIV-vaccinated children using the fluorescent immunospot ass

87 s the many well-trained polio staff who have vaccinated children, conducted surveillance, tested stoo

88 dies in unvaccinated or whole-cell pertussis-vaccinated children.

89 in children, tonsils from seasonal influenza-vaccinated children.

90 in the proportion of unvaccinated and fully vaccinated children.

91 cause bacteremic LRTI and empyema in healthy vaccinated children.

92 iterature on "herd"/indirect protection from vaccinating children aged 6 months to 17 years against i

93 better quantify the indirect protection from vaccinating children for different settings/endpoints.

94 Background: Whether vaccinating children with intranasal live attenuated inf

95 trial, with rates of increase for six orally vaccinated chimpanzees very similar to four intramuscula

96 cell responses were also detected in Triplex-vaccinated CMV-seronegatives, and in DryVax-vaccinated s

97 d communities and Group 3 (n = 39) came from vaccinated communities.

98 ds ratio for influenza test positivity among vaccinated compared to unvaccinated participants.

99 Longer survival times of DC-vaccinated compared with chemotherapy-treated patients w

100 s of circulating CXCL13 were higher in those vaccinated compared with controls, mirroring an increase

101 itis cases declined by 57% (95% CI 55-59) in vaccinated compared with unvaccinated populations, with

102 Adjusted vaccine effectiveness for confirmed vaccinated compared with unvaccinated women was 95.93% (

103 Among case patients, 205 of 368 (55%) were vaccinated, compared with 489 of 773 controls (63%).

104 re after randomisation among all immediately vaccinated contacts and contacts of contacts versus 23 c

105 panzees very similar to four intramuscularly vaccinated controls.

106 SC-Ad-vaccinated cotton rats had markedly lower influenza tite

107 Vaccinated dams challenged with a heterologous ZIKV stra

108 Vaccinating decisions exemplify a complex, coupled syste

109 fected animals, which may lead to disease in vaccinated dogs that are also infectious to sand flies.

110 t distinguish between naturally infected and vaccinated dogs.

111 as also lower for participants consecutively vaccinated during both the current and prior seasons (41

112 Mothers were considered vaccinated during pregnancy if Tdap was received >/=14 d

113 onfirmed influenza illness (PCR-CI) in women vaccinated during pregnancy.

114 easons (41%; 95% CI, 18%-57%) than for those vaccinated during the current season only (75%; 95% CI,

115 ram (RWHAP), 12.5% (CI, 11.1% to 13.9%) were vaccinated during the surveillance period versus 3.7% (C

116 g a 5-year period in California in an cohort vaccinated exclusively with acellular pertussis (aP) vac

117 ntly we reported a vaccine-induced sex bias: vaccinated female but not male rhesus macaques exhibited

118 related with rectal plasma cell frequency in vaccinated female rhesus macaques.

119 Our data suggest that vaccinated females developed better Ab quality, contribu

120 A vaccinated ferret with no detectable HAI-antibodies but

121 2.3.4.4), whereas antisera from dk/Hok/69 ca-vaccinated ferrets cross-reacted with clade 2.3.4.4 and

122 Compared to naive ferrets, all vaccinated ferrets showed improved cellular immunity in

123 When vaccinated ferrets were challenged with homologous and h

124 Vaccinating ferrets with virus-like particle (VLP) vacci

125 vel decreases in CIN among cohorts partially vaccinated for HPV may be considered when clinical pract

126 al vaccine shortage, 1.4 million people were vaccinated from March to June, 2015.

127 lated cancers and herd immunity effects from vaccinating girls and boys.

128 T by neutralising antibody assay in the H5N2 vaccinated group (1395.85 [1040.79-1872.03]) was also si

129 ition antibodies in the previously LAIV H5N2 vaccinated group (566.89 [95% CI 436.97-735.44]) were si

130 Among vaccinated groups (vaccine via health-care worker admini

131 stimulated with E2 and NS3 proteins in both vaccinated groups.

132 rgeted vaccination programs could be used to vaccinate habituated great apes but also human populatio

133 sponses could be elicited in humans requires vaccinating human subjects with a fibroblast-adapted mut

134 h immune sera and monoclonal antibodies from vaccinated humans showed not only high-level ADCC and AD

135 SAT-6 and Ag85B, in Mtb-infected mice and in vaccinated humans with and without underlying Mtb infect

136 y, transfection with long dsRNA specifically vaccinates IFN-deficient cells against infection with vi

137 Specifically, vaccinated immunocompetent mice had significantly faster

138 sk of infection was not observed among those vaccinated in 2 or 3 previous years.

139 -13-year-old girls, of whom 92.4% were fully vaccinated in 2008-09.

140 timated to be 51% (95% CI, 45%-57%) in those vaccinated in both the current and previous season, comp

141 17 and April 21, 2016, 1510 individuals were vaccinated in four rings in Guinea, including 303 indivi

142 y assigned contacts and contacts of contacts vaccinated in immediate clusters versus 16 cases (7 clus

143 ible contacts and contacts of contacts never vaccinated in immediate clusters.

144 A total of 413 subjects were vaccinated in the coadministration group and 415 in the

145 ver, the protection was lower in individuals vaccinated in the current season after >2 prior doses (3

146 s was not statistically lower in individuals vaccinated in the current season only (52%) or in those

147 season, compared with 33% (95% CI, 17%-47%) vaccinated in the current season only and 35% (95% CI, 2

148 nce interval, 49%-78%) was observed in those vaccinated in the current season who had received 1-2 pr

149 children were unvaccinated, 349 mothers were vaccinated in the first trimester, and 5962 mothers were

150 n the first trimester, and 5962 mothers were vaccinated in the second or third trimesters.

151 luenza A and B strains in groups of subjects vaccinated in three different seasons.

152 whom were eligible and 1677 were immediately vaccinated, including 194 children.

153 eed for high vaccination coverage to protect vaccinated individuals and chemoprophylaxis for close co

154 dence of Ebola virus disease in eligible and vaccinated individuals assigned to immediate vaccination

155 nst Ebola virus disease, with no cases among vaccinated individuals from day 10 after vaccination in

156 Development of acute disease in successfully vaccinated individuals is a rare event.

157 s, but their use potentially will predispose vaccinated individuals to infection by the related Dengu

158 Vaccinated individuals were significantly less likely to

159 onships at equilibrium among the fraction of vaccinated individuals, the population size, the basic r

160 s were more likely to be surrounded by other vaccinated individuals.

161 antitoxin immunity exist in the majority of vaccinated individuals.

162 vaccinees were present in 43% of MF59/rgp120-vaccinated infants but only in 12% of the vaccinated adu

163 he effect was caused by herd immunity, since vaccinated infants were more likely to be surrounded by

164 utaneously, which is the preferred route for vaccinating infants, who may develop nasal congestion as

165 , bone marrow, and mesenteric lymph nodes of vaccinated infected, unvaccinated infected, and uninfect

166 wing pathogenic SIV infection in a cohort of vaccinated macaques.

167 Vaccinated male mice challenged with Zika virus were pro

168 peripheral blood mononuclear cells from ESO-vaccinated melanoma patients.

169 Next, we challenged both vaccinated mice and control mice with MERS-CoV after ade

170 CD4(+) T cells from bacillus Calmette-Guerin-vaccinated mice and show that high-quality microarrays c

171 16-ova-Melanoma) protection in around 40% of vaccinated mice and significantly delayed tumor progress

172 Vaccinated mice are protected from lethal challenge with

173 Vaccinated mice had reduced heroin-induced hyperlocomoti

174 Interestingly, Vetera-vaccinated mice produced significantly higher levels of

175 Our results demonstrated that vaccinated mice were fully protected from the MERS-CoV c

176 nst a lethal-dose toxin challenge, but Ty21a-vaccinated mice were not.

177 t epitopes caught up with the conventionally vaccinated mice, and analysis of the breadth of the CD8(

178 in PhtD-vaccinated adult mice, but not PCV13-vaccinated mice, caused a loss of vaccine-induced protec

179 When we vaccinated mice, chemically inactivated BNSP333-S1 induc

180 protection against ocular HSV-1 challenge in vaccinated mice.

181 ic cells did not accumulate in the livers of vaccinated mice.

182 iting an enhanced humoral immune response in vaccinated mice.

183 Initiative has made substantial progress in vaccinating millions of children worldwide, including th

184 class I (MHC-I) tetramer staining in the one vaccinated monkey that was Mamu-A*01 positive.

185 Purified immunoglobulin from vaccinated monkeys also conferred passive protection in

186 Furthermore, one of these vaccinated monkeys appeared to be protected against the

187 During the vaccine phase, plasma of all vaccinated monkeys showed neutralizing activity against

188 Two of four vaccinated monkeys showed no detectable viral RNA after

189 f two unvaccinated controls, two of the four vaccinated monkeys showed no detectable viral RNA sequen

190 immune deficiency syndrome, enabling 50% of vaccinated monkeys to clear a subsequent virulent simian

191 ries of heroin challenges over six months in vaccinated monkeys, drug-sequestering antibodies caused

192 ible adverse effects in offspring of A(H1N1)-vaccinated mothers beyond the perinatal period and into

193 No infants born to vaccinated mothers required intubation or died of pertus

194 s, antibody responses among children born to vaccinated mothers were reduced based on earlier adminis

195 Infected infants of vaccinated mothers were significantly less likely to be

196 cine was assessed in children born to mostly vaccinated mothers.

197 eling to estimate the added effectiveness of vaccinating multiple cohorts of females (12-26 years) in

198 Our results suggest that vaccinating multiple cohorts produced markedly faster di

199 nd RIG-I-like helicase signaling, whereas in vaccinated MyD88(-/-) mice the adjuvant effect was reduc

200 ted by the absence of the adjuvant effect in vaccinated MyD88(-/-)Cardif(-/-) mice, which are devoid

201 Previously vaccinated (n = 395) or unvaccinated (n = 149) male adol

202 re people who are exposed to friends who get vaccinated or are exposed to friends who get the flu.

203 ed with different H1N1 isolates before being vaccinated or infected with another influenza virus.

204 pen-label trial was done in which previously vaccinated participants (40 from LAIV H5N2 group and 20

205 reactions, and 50 (78%) of 64 intradermally vaccinated participants and 29 (78%) of 37 intramuscular

206 st vaccination, 60 (94%) of 64 intradermally vaccinated participants and 36 (97%) of 37 intramuscular

207 ticipants and 36 (97%) of 37 intramuscularly vaccinated participants reported solicited injection sit

208 ticipants and 29 (78%) of 37 intramuscularly vaccinated participants reported solicited systemic adve

209 Of six vaccinated patients, four had no recurrence at 25 months

210 strategy to improve on the effects of BCG in vaccinated people living in tuberculosis-endemic countri

211 nd 0.66/100000 (95% CI, .44-.95 [104 cases]) vaccinated person-years, respectively.

212 make it easier to see when friends have been vaccinated (personalized vaccination campaigns) and when

213 (IIV) in providing both direct protection in vaccinated persons and herd protection in unvaccinated p

214 Many cases occurred in vaccinated persons, showing that pertussis vaccination d

215 ious challenge virus in most of the PLGA-KAg vaccinated pig lung airways were observed.

216 s cytology-screened women in Australia's HPV-vaccinated population (by 2014, resident women </=33 yea

217 and how these could be applied to reach and vaccinate populations in other settings across the world

218 In fully vaccinated populations, the incidence of confirmed group

219 Mumps outbreaks can occur in highly vaccinated populations.

220 e implementation of primary HPV screening in vaccinated populations.

221 ng clinical practice guidelines in partially vaccinated populations.

222 rstanding and refining current approaches to vaccinating populations in conflict and humanitarian eme

223 the Foxp3(+) CD25(+) Treg cell population of vaccinated/ppins-primed mice.

224 est that there may also be large benefits to vaccinating previously infected individuals.

225 on this cocktail approach by simultaneously vaccinating rabbits with a combination of plasmids encod

226 monthly decreases in the number of children vaccinated ranging from -419 (95% CI -683 to -155; p=0.0

227 ere individuals can dynamically adjust their vaccinating strategies and their payoffs depend nonlinea

228 On 14 January 2014, a vaccinated student presented with parotitis.

229 During an outbreak among vaccinated students at the University of Iowa, health of

230 efficacy study, a group of sheep (n = 5) was vaccinated subcutaneously with the glycoprotein-based su

231 Cytokine production by T cells from vaccinated subjects after in vitro stimulation with homo

232 Furthermore, all vaccinated subjects developed protective anti-rabies vir

233 -vaccinated CMV-seronegatives, and in DryVax-vaccinated subjects.

234 sequences were similar in nonvaccinated and vaccinated subjects.

235 in other young children too old to have been vaccinated suggest additional benefit through indirect p

236 icant reductions among cohorts too old to be vaccinated suggest indirect benefits.

237 genetically modified virus, we were able to vaccinate swine and protect them from developing ASF.

238 es were unable to secure sufficient doses to vaccinate the entire at-risk population-approximately 1

239 It took 10 days to vaccinate the first participant following the confirmati

240 reduce RSV in the elderly more than directly vaccinating the elderly themselves.

241 Parents hesitant to vaccinate their children may delay routine immunizations

242 jects with preexisting immunity to DENV were vaccinated, they developed higher levels of neutralizing

243 verage, likely because campaigns necessarily vaccinate those who may already be immune.

244 Usually, individuals decide whether to vaccinate through evaluating the relative cost of vaccin

245 Furthermore, the number needed to vaccinate to prevent 1 anogential warts (AGW) case or ce

246 women, with 2-fold fewer women needing to be vaccinated to prevent SDI (4; 95% CI, 3-8) than PCR-CI (

247 Pigs vaccinated twice with PLGA-KAg via intranasal route show

248 analyze the antibody repertoire in subjects vaccinated two years in a row with either identical vacc

249 urse of a more chronic viral infection, mice vaccinated using the vaccine targeting subdominant epito

250 6/11 infections was significantly reduced in vaccinated versus unvaccinated individuals (0.11% v 1.61

251 6/11 infections was significantly reduced in vaccinated versus unvaccinated men (0.0% v 2.13%; Padj =

252 s ratios (ORs) comparing disease outcomes in vaccinated versus unvaccinated participants via multivar

253 r testing positive for influenza virus among vaccinated versus unvaccinated participants.

254 eutralize viruses isolated after 2013 from a vaccinated volunteer.

255 Vaccinated volunteers had an immunodominant response to

256 unization, nine (64%) of 14 (95% CI, 35-87%) vaccinated volunteers remained without parasitemia compa

257 mal cervical cytology result was lower among vaccinated vs unvaccinated females (hazard ratio [HR], 0

258 stment, stillbirth was 51% less likely among vaccinated vs unvaccinated mothers (aHR, 0.49; 95% confi

259 Most MMR-eligible travelers who were not vaccinated were evaluated in the South (2262 travelers [

260 y infants aged 6 weeks, not previously polio vaccinated, were allocated after computer-generated rand

261 with dengue disease for individuals who are vaccinated when seronegative.

262 d vaccination strategy, in which miners were vaccinated while in the mines, with that of a community-

263 They were vaccinated with 1 dose (20 microg) of recombinant HBV va

264 ubjects were randomized 2:2:2:2:1; 1194 were vaccinated with 1 dose of 1 of 3 lots of rVSVDeltaG- ZEB

265 All patients were vaccinated with 23vPPV before transplantation.

266 Groups of sheep vaccinated with a cocktail of six different vaccines wer

267 these studies, we found that when mice were vaccinated with a combination of CPS-CRM197 and Hcp1, 10

268 cryopreserved PBMC obtained from volunteers vaccinated with a recombinant HIV envelope protein.

269 ly, ferrets infected with the 1986 virus and vaccinated with a single dose of the COBRA HA VLP vaccin

270 blood mononuclear cells (PBMCs) from donors vaccinated with a tetravalent DLAV vaccine (TV005) with

271 ior and durable B-cell responses in macaques vaccinated with an occluded CD4 binding site on the HIV

272 sponse to B. pertussis infection in children vaccinated with aP vaccines.

273 possesses the glycosylation site) and humans vaccinated with baculovirus-expressed H3 antigens (that

274 erved a marked increase in skin Treg in mice vaccinated with Ccl22, with repetitive vaccination suffi

275 Macaques were aerosol-vaccinated with DeltasigH and subsequently challenged wi

276 lung pathology was observed only in animals vaccinated with FI-RSV, but not in animals vaccinated wi

277 mmunized with GP-alone or GP-alpha-syn, mice vaccinated with GP+RAP or GP+RAP/alpha-syn displayed inc

278 Among 73 infants not vaccinated with IPV, 58% of caregivers reported that vac

279 ) of 40 participants who had previously been vaccinated with LAIV H5N2 had an increase in haemaggluti

280 anticoagulated blood from 12 healthy adults vaccinated with meningococcal serogroup B and serogroup

281 Mice vaccinated with our designed immunogens produced robust

282 We recruited persons from a cohort vaccinated with plasma-derived hepatitis B vaccine in 19

283 BALB/c mice were vaccinated with rFlaA:Betv1 in an experimental Bet v 1 s

284 The animals vaccinated with the cVLP showed 20% cross-protection aga

285 at monoclonal antibodies derived from humans vaccinated with the HVEM binding domain of HSV-1 gD (i)

286 of people worldwide, most of whom have been vaccinated with the partially effective Mycobacterium bo

287 e the CD8 T cell responses of human subjects vaccinated with two fibroblast-adapted HCMV vaccines.

288 s vaccinated with FI-RSV, but not in animals vaccinated with unadjuvanted or adjuvanted RSV-G vaccine

289 HA VLP vaccines than COBRA preimmune ferrets vaccinated with VLP vaccines expressing wild-type HA pro

290 challenged newborn mice born to female mice vaccinated with VSVm-ZENV containing the transmembrane d

291 Cattle were vaccinated with wild-type PPRV or either of two establis

292 Mice vaccinated with wild-type SpeA rendered Vbeta8(+) T cell

293 d the antibody responses in girls previously vaccinated with zero, 1, 2, or 3 doses of quadrivalent H

294 ulticenter study, adults >/=65 years of age, vaccinated with ZVL >/=5 years previously (HZ-PreVac), w

295 Of 3736 eligible samples, 822 were from vaccinated women according to immunization record, 1021

296 rios that offer less intensive screening for vaccinated women and more on increasing coverage and inc

297 Increased cervical screening uptake in vaccinated women from ethnic minorities would lead to ra

298 significantly lower (0.61%) among confirmed-vaccinated women than among those who self-reported vacc

299 fectiveness of the bivalent vaccine in these vaccinated women who attended for routine cervical scree

300 women, and using a microsimulation model for vaccinated women.